Busch Albert, Bleichert Sonja, Ibrahim Nahla, Wortmann Markus, Eckstein Hans-Henning, Brostjan Christine, Wagenhäuser Markus U, Goergen Craig J, Maegdefessel Lars
Department for Vascular and Endovascular Surgery, Technical University Munich, Munich, Germany.
Deutsches Zentrum für Herz-Kreislaufforschung (DZHK), Berlin, Germany.
JVS Vasc Sci. 2021 Mar 3;2:219-234. doi: 10.1016/j.jvssci.2021.01.002. eCollection 2021.
Abdominal aortic aneurysm (AAA) is a condition that has considerable socioeconomic impact and an eventual rupture is associated with high mortality and morbidity. Despite decades of research, surgical repair remains the treatment of choice and no medical therapy is currently available. Animal models and, in particular, murine models, of AAA are a vital tool for experimental in vivo research. However, each of the different models has individual limitations and provide only partial mimicry of human disease. This narrative review addresses the translational potential of the available mouse models, highlighting unanswered questions from a clinical perspective. It is based on a thorough presentation of the available literature and more than a decade of personal experience, with most of the available models in experimental and translational AAA research.
From all the models published, only the four inducible models, namely the angiotensin II model (AngII), the porcine pancreatic elastase perfusion model (PPE), the external periadventitial elastase application (ePPE), and the CaCl model have been widely used by different independent research groups. Although the angiotensin II model provides features of dissection and aneurysm formation, the PPE model shows reliable features of human AAA, especially beyond day 7 after induction, but remains technically challenging. The translational value of ePPE as a model and the combination with β-aminopropionitrile to induce rupture and intraluminal thrombus formation is promising, but warrants further mechanistic insights. Finally, the external CaCl application is known to produce inflammatory vascular wall thickening. Unmet translational research questions include the origin of AAA development, monitoring aneurysm growth, gender issues, and novel surgical therapies as well as novel nonsurgical therapies.
New imaging techniques, experimental therapeutic alternatives, and endovascular treatment options provide a plethora of research topics to strengthen the individual features of currently available mouse models, creating the possibility of shedding new light on translational research questions.
腹主动脉瘤(AAA)是一种具有重大社会经济影响的疾病,其最终破裂与高死亡率和高发病率相关。尽管经过数十年的研究,手术修复仍是首选治疗方法,目前尚无可用的药物治疗。AAA的动物模型,尤其是小鼠模型,是体内实验研究的重要工具。然而,每种不同的模型都有各自的局限性,只能部分模拟人类疾病。本叙述性综述探讨了现有小鼠模型的转化潜力,从临床角度突出未解决的问题。它基于对现有文献的全面介绍以及十多年的个人经验,涉及实验性和转化性AAA研究中的大多数可用模型。
在所有已发表的模型中,只有四种诱导性模型,即血管紧张素II模型(AngII)、猪胰弹性蛋白酶灌注模型(PPE)、外膜周围弹性蛋白酶应用模型(ePPE)和氯化钙模型,被不同的独立研究小组广泛使用。尽管血管紧张素II模型具有夹层和动脉瘤形成的特征,但PPE模型显示出可靠的人类AAA特征,尤其是在诱导后第7天之后,但在技术上仍然具有挑战性。ePPE作为一种模型的转化价值以及与β-氨基丙腈联合诱导破裂和腔内血栓形成很有前景,但需要进一步的机制研究。最后,外用氯化钙已知会导致炎症性血管壁增厚。未解决的转化研究问题包括AAA发展的起源、动脉瘤生长的监测、性别问题、新型手术治疗以及新型非手术治疗。
新的成像技术、实验性治疗替代方案和血管内治疗选择提供了大量研究课题,以强化现有小鼠模型的个体特征,为转化研究问题带来新的启示。